Showing results (51-60 of 208) with videos related to
Sort By:
Pageof 21
BMC Medical Genomics|November 27, 2010
An empirical Bayes model for gene expression and methylation profiles in antiestrogen resistant breast cancerJaesik Jeong, Lang Li, Yunlong Liu, et al.Methods (San Diego, Calif.)|August 2, 2016
BioVLAB-mCpG-SNP-EXPRESS: A system for multi-level and multi-perspective analysis and exploration of DNA methylation, sequence variation (SNPs), and gene expression from multi-omics dataHeejoon Chae, Sangseon Lee, Seokjun Seo, et al.Cancer Letters|June 21, 2011
GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy responseBaishen Chen, Xi Rao, Michael G House, et al.Cancer Research|January 14, 2010
Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-betKasi McCune, Poornima Bhat-Nakshatri, Mangesh A Thorat, et al.Alcoholism, Clinical and Experimental Research|January 13, 2011
Alcohol alters DNA methylation patterns and inhibits neural stem cell differentiationFeng C Zhou, Yokesh Balaraman, MingXiang Teng, et al.Gynecologic Oncology|November 6, 2025
The 15th Biennial Rivkin Center ovarian cancer research symposiumKenneth P Nephew, Ronny Drapkin, Jackie Lang, et al.BMC Genomics|October 10, 2008
A Poisson mixture model to identify changes in RNA polymerase II binding quantity using high-throughput sequencing technologyWeixing Feng, Yunlong Liu, Jiejun Wu, et al.Research Square|June 29, 2026
ERG function in prostate cells is regulated by distinct positive feedback loops depending on AKT signaling statusPeter Hollenhorst, Saranya Rajendran, Ethan Golditch, et al.Breast Cancer Research and Treatment|October 13, 2006
Characterization of molecular and structural determinants of selective estrogen receptor downregulatorsMeiyun Fan, Emily L Rickert, Lei Chen, et al.Targeted Oncology|December 13, 2017
Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic ReviewMichal Chovanec, Fadi Taza, Maitri Kalra, et al.Pageof 21